Fig. 1From: Clinically relevant prognostic and predictive markers for immune-checkpoint-inhibitor (ICI) therapy in non-small cell lung cancer (NSCLC)Comprehensive overview about the different positive prognostic and predictive factors in treating patients with ICI discussed in the reviewBack to article page